Navigation Links
Iomai Announces Data from Phase 2 Field Study of Travelers' Diarrhea Vaccine Accepted for Presentation at ICAAC
Date:8/23/2007

settings where health care is inadequate. Additionally, 10 to 30 percent of travelers who contract diarrhea also develop a more chronic condition, irritable bowel syndrome.

About Iomai Corporation

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin (Langerhans cells) to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, develop new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. Iomai currently has four product candidates in development: three targeting influenza and pandemic flu and one to prevent travelers' diarrhea. For more information on Iomai, please visit http://www.iomai.com.


'/>"/>
SOURCE Iomai Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Iomai to Announce Results From Phase 1 Influenza Trial and Host Webcast Tomorrow
2. Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers Diarrhea Stimulates Immune Response Even at Low Doses
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 Amgen (NASDAQ: AMGN ) announced ... per share dividend for the third quarter of 2015. ... to all stockholders of record as of the close ... About Amgen Amgen is committed to unlocking the potential ... discovering, developing, manufacturing and delivering innovative human therapeutics. This ...
(Date:7/28/2015)...   Regulus Therapeutics Inc . ( NASDAQ: RGLS ... of innovative medicines targeting microRNAs, today announced that it ... ended June 30, 2015 on Tuesday, August 4, 2015, ... Regulus will host a conference call and webcast on ... Time to discuss its second quarter 2015 financial results ...
(Date:7/28/2015)... Calif. , July 28, 2015 On ... Corp., the parent company of CPI International, Inc. (CPI), ... quarter ended July 3, 2015 with the Securities and ... its results for the quarter.  At 11 a.m. (EDT) ... telephonic conference call in conjunction with this release that ...
Breaking Medicine Technology:Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3CPI International To Announce Third Quarter 2015 Financial Results 2
... of Body Consistent with Overall PASI ... Response in REMICADE-Treated Patients, SAN ANTONIO, Feb. ... trials showed patients with moderate,to severe plaque psoriasis receiving REMICADE(R) ... of the four body regions,(head, trunk, lower and upper extremities) ...
... PRINCETON, N.J., Feb. 4 Pharmacopeia (Nasdaq:,PCOP), an ... small,molecule therapeutics, today announced that Dr. Leslie J. ... corporate presentation at the,BIO CEO & Investor Conference ... at The Waldorf-Astoria Hotel in New York City., ...
Cached Medicine Technology:REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 2REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 3REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 5REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 6REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 7REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 8REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 9REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 10Pharmacopeia to Present at BIO CEO & Investor Conference 2008 2Pharmacopeia to Present at BIO CEO & Investor Conference 2008 3
(Date:7/28/2015)... ... ... Santa Rosa’s The Press Democrat announced its annual report of the very best facilities in ... Furnas took the top spot as the Best Cosmetic Surgeons in Sonoma County . ... be bestowed such a prestigious title. , The Press Democrat was Santa Rosa’s ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Hospital examines outcomes for inmates who continued methadone maintenance treatment (MMT) during incarceration ... more likely to relapse to opiate use (1) and more likely to require ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Morristown Medical ... New Jersey, and one of the first five hospitals in the nation, to implant ... three patients on July 23, and all are in good condition. , The CoreValve® ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Healthline , ... a recent survey (1) examining consumers’ perspectives on digital health . The ... covered topics such as innovations in digital health, level of trust in the security ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Aziz Ahmad recently gave ... took place from noon to 1 p.m. Tuesday, June 23, at the Gulf Coast ... , Dr. Ahmad is board-certified in colorectal surgery and has more than 35 years ...
Breaking Medicine News(10 mins):Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2
... Governor Walker to join University of Utah ... SAN JOSE, Calif., July 16 Olene Walker has been interviewed ... this month will likely be the most compelling from the former Utah governor. ... her personal struggle with a fatal lung disease. , ...
... , ALEXANDRIA, Va., July 16 Ensuring that ... the event of a healthcare crisis is what advance care ... Care Organization,s Caring Connections, a leading provider of advance care ... the availability and accessibility of advance care planning information and ...
... , Archer: "We,re Determined to Make the House Bill ... for Reform " , , ... director Diane Archer today praised the House for introducing a health reform ... Health Choices Act is designed to control costs and deliver quality affordable health care ...
... , , COLUMBUS, Ohio, July 16 ... visits is the goal of a new program announced by the Ohio ... The Medicaid plans serve families and dependent children, a group that includes ... , Keep Up with Checkups will ...
... unable to get LASIK, researchers say , THURSDAY, July ... laser-assisted eye surgery may benefit from implantable lenses made ... noted that LASIK "has gained widespread popularity as a ... but patients with high [severe] myopia or thin corneas ...
... , WORCESTER, Mass., July 16 Board-certified facial ... and only FDA-approved microsphere-enhanced collagen filler for the correction of smile ... dermal filler. Dr. Fechner has been an avid Artefill user the ... the correction of deep wrinkles. , , ...
Cached Medicine News:Health News:Former Utah Governor to Talk About Her Battle With PF on ABC 4 Salt Lake City, July 22nd 2Health News:Former Utah Governor to Talk About Her Battle With PF on ABC 4 Salt Lake City, July 22nd 3Health News:National Hospice and Palliative Care Organization's Caring Connections and Google Health Offer New Way to Access Advance Directives Online 2Health News:'Keep Up With Checkups' Puts Prevention First 2Health News:New Option for Correcting Nearsightedness 2Health News:Facial Plastic Surgeon Dr. Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 2Health News:Facial Plastic Surgeon Dr. Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: